Antidyslipidemic and antioxidant activities of different fractions of Terminalia arjuna stem bark

Indian Journal of Clinical Biochemistry

Volumn 19, Issue 2, 2004, Pages 141-148

  Chander, Ramesh ^a   Singh, Kavita ^a   Khanna, A K ^a   Kaul, S M ^a   Puri, Anju ^a   Saxena, Rashmi ^a   Bhatia, Gitika ^a   Rizvi, Farhan ^a   Rastogi, A K ^a  

^a CENTRAL DRUG RESEARCH INSTITUTE   (India)

Author keywords

Antidyslipidemic activity; Antioxidant activity; Hamster model; Terminalia arjuna oxygen free radical; Triton model

Indexed keywords

ALCOHOL; CHOLESTEROL; FRUCTOSE; GLUCOSE; GLYCEROL; HYDROXYL RADICAL; LIPID; LOW DENSITY LIPOPROTEIN; METAL ION; OXYGEN RADICAL; PETROLEUM ETHER; PHOSPHOLIPID; SOLVENT; SUPEROXIDE; TERMINALIA ARJUNA EXTRACT; TRIACYLGLYCEROL; TYLOXAPOL; WATER;

ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; BARK; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; GLUCOSE BLOOD LEVEL; GLYCEROL BLOOD LEVEL; HAMSTER; HYPERLIPIDEMIA; IN VITRO STUDY; IN VIVO STUDY; LIPID DEGRADATION; LIPID DIET; LIVER MICROSOME; MALE; NONHUMAN; OXIDATION; PHOSPHOLIPID BLOOD LEVEL; RAT; TERMINALIA; TRIACYLGLYCEROL BLOOD LEVEL;

ANIMALIA; CRICETINAE; TERMINALIA; TERMINALIA ARJUNA;

EID: 3943069800     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02894274     Document Type: Article

References (38)

1. Nandkarni, A.K. (1976) In Indian Materia Medica. (eds. Nandkarni, A.K. and Nandkarni, K.M.), Popular Prakashan Private Limited, Mumbai, Vol. 1, 1199-1202.
2. Nesamony, S. (1988) Ovshadhya Sasyangai (Medicinal plants). State Institute for Language Kerala, India, pp. 314-316.
3. Tiwari, A.K., Gode, J.D. and Dubey, G.P. (1990) Effect of Terminalia arjuna on lipid profiles of rabbits fed hypercholesterolemic diet. Int. J. Crude Drug Res. 28, 43-47.
4. Khanna, A. K., Chander, R. and Kapoor, N.J. (1996) Terminalia arjuna an Ayurvedic cardiotonic regulates lipid metabolism in hyperlipaemic rats. Phytotherapy Res. 10, 663-665.
5. Shaila, H.P., Udupa, S.L., Udupa, A.L., Nair, N.S. (1997) Effect of Terminalia arjuna on experimental hyperlipidemia in rabbits. Int. J. Pharmacol. 35, 1-4.
6. Gauthaman, K., Maulik, M., Kumari, R., Manchandra, S.C., Dinda, A.K. and Maulik, S.K. (2001) Effect of chronic treatment with bark of Terminalia arjuna a study in isolated ischemic-reperfused rat heart. J. Ethnopharmacol. 75, 197-201.
7. Dwivedi, S. and Gupta, D. (2002) Efficacy of Terminalia arjuna in chronic stable angina. Ind. Heart J. 54, 170-175.
8. Gupta, R. and Nair, S. (1997) Antioxidant flavonoides in Indian diet. In: Current Advances in Atherosclerosis Research Part I, Shyam Singh, Ed., Central Drug Research Institute, 35-50.
9. nd International Electronic Conference on Synthetic Organic Chemistry (ECSOC-2), Sept, 1-30 pp. dp 002.
10. Kaur, K., Arora, S., Kumar, S. and Nagpal, A. (2002) Antimutagenic activities of acetone and methanol fractions of Terminalia arjuna. Food Chem. Toxicol. 40, 1475-1482.
11. Sumitra, M., Manikandan, P., Kumar, A.D., Arutselven, N., Balakrishna, K., Manohar, M.B. and Puvanakrishnan, R. (2001) Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status. Mol. Cell. Biochem. 224, 135-142.
12. Row, L.R., Murty, P.S., Rao, G.S.R., Sastry, C.S.P. and Rao, K.V.J. (1070) Chemical examination of Terminalia species: Part XII-Isolation and structure determination of arjunic acid, a new trihydroxytriterpene carboxylic acid from Terminalia arjuna bark. Ind. J. Chem. 8, 716-721.
13. Deeg, R. and Ziegenhorn, J. (1983) Kinetic enzymetic method for automated determination of total cholesterol in serum. Clin. Chem. 29, 1798-1803.
14. Buccolo, G. and David, H. (1973) Quantitative determination of serum triglycerides by the use of enzymes. Clin. Chem. 19, 476-480.
15. Zilversmit, D.B., Davis, A.K., Memphis, B.S. and Tenn (1950) Microdetermination of plasma phospholipids by trichloroacetic acid precipitation. J. Lab. Clin. Med. 35, 155-160.
16. Gordon, D.J., Probstfield, J.L., Garrison, R.J, Neaton, J.D., Jacobs, D.R., Jr. Bangdiwala, S. and Tyroler, H.A. (1989) High-density lipoprotein cholesterol and cardiovascular Disease: four prospective American studies. Circulation, 79, 8-14.
17. Trinder, P. (1969) Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann. Clin. Biochem. 6, 24-30.
18. Mc Gowan, M.W., Artiss, J.D., Strandbergh, D.R. and Zak, B. (1983) A peroxidase coupled method for the colorimetric determination of glycerol. Clin. Chem. 29, 538-542.
19. Wako pure Chemicals Ltd. NAFAC, Quantitative determination of free fatty acid in serum by ACS-ACOD method. Company Code No. 994-75409E.
20. Havel, R.J., Edor, H.A. and Bingdon, J.A. (1955) The distribution and chemical composition of Ultra centrifugically separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353.
21. Okhawa, H. Qohishi (1978) Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal. Biochem. 95. 351-358.
22. Devasagayan, T.P.A. and Tarachand, U. (1987) Decrease lipid peroxidation in rat kidney during gestation. Biochem. Biophys. Res. Comm. 145, 134-138.
23. Bindoli, A., Valente, M. and Cavallin, L. (1985) Inhibition of xanthine oxidase and xanthine dehydrogenase activity. Pharmacol. Res. Commun. 17, 831-839.
24. Halliwell, B., Gutteridge, J.M.C. and Arouma, O. (1987) The deoxyribose method: A simple test tube assay for determination of rate constants for reaction of OH radicals. Anal. Biochem. 165, 215-219.
25. Parthasrthy, S., Steinbert, D., Switztum, J.L. (1992) The role of oxidized low- density lipoproteins in the pathogenesis of atherosclerosis. Annu. Rev. Med. 43, 219-225.
26. Stehouwer, C.D.A., Lambert, J., Donker, A. J.M and Vanhinsbergh, V.W.M. (1997) Endothelial dysfunction and pathogenesis of diabetic angiopathy. Cardiovasc. Res. 34, 55-61.
27. 2 in high glucose medium. Diabetes, 44, 520-526.
28. Schurr, P.E., Schultz, J.R. and Parkinson, T.M. (1972) Triton induced hyperlipidemia in rats as an animal model for screening of hypolipidemic drugs. Lipids 7, 68-74.
29. Rizvi, F., Puri, A., Bhatia, G., Khanna, A.K., Wulff, E.M., Rastogi, A.K. and Chander, R. (2003) Antidyslipidemic action of fenofibrate in dyslipidemic- diabetic hamster model. Biochem. Biophys. Res. Comm. 305, 215-222.
30. Chander, R., Rizvi, F., Khanna, A. K. and Pratap, R. (2003) Cardioprotective activity of synthetic Guggulsterone (E and Z isomers) in isoproterenol induced myocardial Ishemia in rats: A comparative study. I.J.E.B. 18, 71-79.
31. Overtuft, M.L. and Loose, M.D.C. (1992) In vivo model system: The choice of the experimental model for the analysis lipoproteins and atherosclerosis. Curr. Opinn. Lipidol. 3, 179.
32. Owens, D. R. (1996) Insulin secretion and sensitivity in newly diagnosed NIDDM Caucasions in UK. Diabet. Med. 13, S19-S24.
33. Halliwell, B. and Gutteridge, J.N.C. (1989) In: Free radicals in Biology and Medicine. 2nd ed, Clarendon Pess, Oxford.
34. Chander, R. Kapoor, N.K. and Dhawan, B. N. (1992) Picroliv, Picroside-1 and Kutkoside from Picrorhiza kurrooa are scavengers of superoxide anions. Biochem. Pharmacol. 44,180-183.
35. Row, L. R., Murti, D.S., Subba Rao, G.S.R., Sastry, C.S.P. and Rao, K.V.F. (1970) Chemical examination of Terminalia species: Part III- Isolation and structure determination of arjunetin from Terminalia arjuna, species. Ind. J. Chem. 8, 772-775.
36. Ali, A., Kaur, G., Hamid, H., Abdullah, T., Ali, M., Niwa, M. and Alam, M.S. (2003) Terminoside A, a new triterpene glycoside from the bark of Terminalia arjuna inhibits nitric oxide production in murine macrophages. J. Asian Nat. Prod. Res. 5, 137-142.
37. Singh, K., Khanna, A. K., Visen, P.K.S. and Chander, R. (1999) Protective effect of ellagic acid on t-butyl hydroperoxide induced peroxidation in isolated rat hepatocytes. Ind. J. Exp. Biol. 37, 939-940.
38. Singh, K., Khanna, A.K. and Chander, R. (1999) Hepatoprotective activity of ellagic acid against carbon tetrachloride induced hepatotoxicity in rats. Ind. J. Exp. Biol. 37, 1025-1026.